Page last updated: 2024-08-23

itanoxone and aspirin

itanoxone has been researched along with aspirin in 1 studies

*Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) [MeSH]

*Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Gaetano, G; Delhon, A; Lauressergues, H; Livio, M; Maynadier, B; Palmier, C; Villa, S1

Other Studies

1 other study(ies) available for itanoxone and aspirin

ArticleYear
Differential effects of itanoxone--a new hypolipidemic and hypouricemic drug--on platelet and vascular prostaglandin generation in rats.
    Atherosclerosis, 1981, Volume: 39, Issue:4

    Topics: Animals; Aspirin; Biphenyl Compounds; Blood Platelets; Blood Vessels; Butyrophenones; Dose-Response Relationship, Drug; Hypolipidemic Agents; Male; Malondialdehyde; Prostaglandins; Rats; Thromboxane B2; Uricosuric Agents

1981